The number of people with susceptibility test result for rifampicin in Sweden
Sweden: The number of people with susceptibility test result for rifampicin was 96.65 in 2021. ▬ Flat
Latest (2021)
96.65
Change on year
up 0.1%
World rank
42nd
of 146 countries
All-time high
98.94
in 2018
All-time low
96.3
in 2019
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Sweden, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Sweden is 96.65, measured in 2021.
The figure is up 0.1% on the previous year and down 0.7% over five years.
Sweden ranks 42nd of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Sweden, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 97.3 | — |
| 2018 | 98.94 | +1.7% |
| 2019 | 96.3 | -2.7% |
| 2020 | 96.57 | +0.3% |
| 2021 | 96.65 | +0.1% |
Sweden compared with similar countries
- Sweden's 96.65 is above the median for high income countries, which is 92.6, 1.0× the median. (56 countries reporting)
- Sweden's 96.65 is above the median for Europe & Central Asia, which is 93.52, 1.0× the median. (43 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 97.51 | 96.3 | 98.94 | 3 |
| 2020s | 96.61 | 96.57 | 96.65 | 2 |
Countries ranked near Sweden
More health data for Sweden
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.8581 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,109 deaths per 1,000 people (2090)
- Number of infants who die before age 1 30 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.12 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0243 units per person (2025)
- Population ages 00-04, male, annual growth rate -3.2 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Sweden?
- The number of people with susceptibility test result for rifampicin in Sweden was 96.65 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Sweden?
- The highest recorded value was 98.94 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Sweden?
- The lowest recorded value was 96.3 in 2019.
- How does Sweden rank for the number of people with susceptibility test result for rifampicin?
- Sweden ranks 42nd out of 146 countries with data for 2021.
- Where does this Sweden data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).